Sign in

CIK 0001133416

  • Non-accelerated filer
  • Smaller reporting company

GALECTIN THERAPEUTICS INC

Sign in to watch
Ticker
GALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
043562325
Phone
+1 678-620-3186
Business address
4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
Former names
PRO PHARMACEUTICALS INC
  1. 4 Open-market buy Director bought 2,000 shares at $3.19 ($6,380)
  2. 4 Open-market sale 10% owner sold 10,000 shares at $3.37 ($33,700)
  3. 4 Open-market buy Director bought 3,000 shares at $3.37 ($10,107)
  4. 4 Grant or award President and CEO acquired 4,946 shares (grant or award)
  5. 4 Open-market sale 10% owner sold 10,000 shares at $3.62 ($36,200)
  6. 4 Grant or award President and CEO acquired 4,296 shares (grant or award)
  7. 4 Open-market buy Director bought 3,000 shares at $3.88 ($11,631)
  8. 4 Derivatives Options or other derivatives
  9. 4 Grant or award President and CEO acquired 4,468 shares (grant or award)
  10. 4 Open-market sale 10% owner sold 10,000 shares at $3.91 ($39,100)
  11. 4 Grant or award President and CEO acquired 4,241 shares (grant or award)
  12. 4 Grant or award President and CEO acquired 4,931 shares (grant or award)
  13. 4 Open-market sale 10% owner sold 10,000 shares at $3.25 ($32,500)
  14. 4 Grant or award President and CEO acquired 6,061 shares (grant or award)
  15. 4 Grant or award President and CEO acquired 6,435 shares (grant or award)
  16. 4 Open-market sale 10% owner sold 10,000 shares at $3.54 ($35,400)
  17. 4 Grant or award President and CEO acquired 5,208 shares (grant or award)
  18. 4 Grant or award President and CEO acquired 4,762 shares (grant or award)
  19. 4 Open-market sale 10% owner sold 10,000 shares at $3.91 ($39,100)
  20. 4 Grant or award President and CEO acquired 4,198 shares (grant or award)

Page 12 of 39 · 776 filings